Loading...
Country's Decision or any other Communication (DEC)
  |  
BCH-DEC-KE-116216-1   |   PDF   |   Print   |  
| 
last updated: 23 Jun 2021
Amendment
No
General Information
Application to conduct contained use activity involving confined field trials of transgenic sorghum containing provitamin A and enhanced iron and zinc bio-availability at KALRO Kiboko.
EN
04 Mar 2015
No
Subject of the decision, notification, communication or declaration
  • Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
LMOs for intentional introduction into the environment
No
No
Yes
No
No
Result of the decision
Approval of the import and/or use of the LMO(s) with conditions
The approval was granted to conduct confined field trials only.
EN
This is a contained use application
EN
LMO identification & risk assessment
  • BCH-LMO-SCBD-103628-6 Living Modified Organism Sorghum with modified levels of vitamin A, zinc and iron
    Changes in quality and/or metabolite content (Vitamins)
  • BCH-RA-KE-115585-2 Risk Assessment generated by a regulatory process Summary risk assessment report on the application to conduct Confined Field Trials of transgenic Sorghum containing pro-vitamin A and enhanced Iron and Zinc bio-availability.
    Sorghum with modified levels of vitamin A, zinc and iron | Sorghum, Changes in quality and/or metabolite content
Document on the decision, communication, notification or declaration